June 7, 2022
Vaccines and Related Biological Products Advisory Committee (VRPBAC)
Slide 8: “U.S. reports to VAERS of myocarditis after mRNA COVID-19 vaccination among people ages 18 years and older following primary series and 1st booster (as of May 26, 2022)
Preliminary reports of myocarditis (N=1836)
Met CDC definition (N=1321)
document
adverse events,COVID-19,heart disorders,mRNA,vaccines